Vaxcyte Inc.
(PCVX)
undefined
undefined%
At close: undefined
87.72
-0.02%
After-hours Dec 13, 2024, 05:19 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Revenue | - | - | - | - | - | - | - |
Cost of Revenue | 75.00M | 9.20M | 1.80M | 1.41M | 1.23M | 1.04M | - |
Gross Profit | -75.00M | -9.20M | -1.80M | -1.41M | -1.23M | -1.04M | - |
Operating Income | -468.04M | -232.26M | -103.67M | -89.58M | -54.15M | -35.53M | -17.83M |
Interest Income | 62.91M | 8.36M | 344.00K | 244.00K | 632.00K | 903.00K | 164.00K |
Pretax Income | -402.27M | -223.49M | -100.08M | -89.22M | -50.27M | -29.48M | -17.24M |
Net Income | -402.27M | -239.64M | -100.08M | -87.82M | -53.50M | -29.48M | -17.24M |
Selling & General & Admin | 60.70M | 39.81M | 25.26M | 16.02M | 8.55M | 5.39M | 5.05M |
Research & Development | 332.34M | 169.45M | 78.41M | 73.56M | 45.61M | 30.14M | 12.79M |
Other Expenses | - | -1.93M | -1.58M | -2.48M | -237.00K | 5.18M | - |
Operating Expenses | 468.04M | 207.33M | 102.08M | 87.10M | 53.92M | 35.53M | 17.40M |
Interest Expense | - | 2.00K | 7.00K | 7.00K | 40.00K | 75.00K | - |
Selling & Marketing Expenses | - | - | - | - | - | - | - |
Cost & Expenses | 468.04M | 207.33M | 102.08M | 87.10M | 53.92M | 35.53M | 17.40M |
Income Tax | - | 16.16M | 7.00K | -1.40M | 3.23M | 6.12M | - |
Shares Outstanding (Basic) | 97.16M | 64.88M | 51.92M | 51.07M | 48.86M | 25.60M | 3.56M |
Shares Outstanding (Diluted) | 97.16M | 64.88M | 51.92M | 51.07M | 48.86M | 25.60M | 3.57M |
EPS (Basic) | -4.14 | -3.69 | -1.93 | -1.72 | -1.09 | -1.15 | -4.84 |
EPS (Diluted) | -4.14 | -3.69 | -1.93 | -1.72 | -1.09 | -1.15 | -4.83 |
EBITDA | -464.88M | -214.29M | -98.28M | -87.81M | -49.00M | -28.37M | -17.21M |
Depreciation & Amortization | 3.16M | 9.20M | 1.80M | 1.41M | 1.23M | 1.04M | 625.00K |